Pricing

Brainstorm Cell Therapeutics

1 follower

‌

BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's diseas...

Industries

Headquarters

Qiryat Shemona, Israel

Employees

Links

Org chart

Chief Executive Officer

Chaim Lebovits

Collapse

Quality Assurance Manager

Chief Commercial Officer

Mary Kay Turner

VP of Patient Advocacy and Government Affairs

VP Research & Development

EVP, Chief Business Officer

Qualified Person (qp)

Process Development Manager

Antal Pearl-Lendner

General Counsel And VP

Haro Hartounian

Chief Operating Officer

Netta Blondheim Shraga

SVP R&d

Teams

Leadership Team

6 members

Regulatory and Clinical Operations

4 members

Quality Control and Assurance

4 members

Research and Development Team

4 members

Similar companies

Ventyx Biosciences

1 follower

Pyxis Oncology

1 follower

Thermo Fisher Scientific

155 followers

Alexion Pharmaceuticals

34 followers

NeoGenomics

8 followers

Roche

235 followers

Alector

3 followers

Grifols

21 followers

BioAgilytix

1 follower

Anthropic

50 followers

Longeveron

1 follower

Explore companies